Science & academia

This archive covers milestones and breakthroughs from the scientific and academic world — researchers, universities, and institutions whose work advances human knowledge. Stories here highlight discoveries, studies, and scholarly efforts that point toward a better future.

Brain model, for article on glioblastoma vaccine

Vaccine prolongs life of patients with aggressive brain cancer in new trial

By / / Good News For Humankind

Glioblastoma patients now have the most promising new treatment in nearly three decades, after a personalised vaccine more than doubled five-year survival rates in a large international trial. The vaccine works by extracting proteins from a patient’s own tumour and combining them with their white blood cells, training the immune system to recognise and destroy the cancer — with benefits seen even among those traditionally considered hardest to treat. If regulators approve it, this could signal a new era of personalised immunotherapy for cancers that have long resisted every available option.

Rolls-Royce & easyJet hydrogen engine, for article on hydrogen jet engine

World’s first test run of a hydrogen jet engine proves a success

By / / Good News For Humankind

Hydrogen-powered flight moved from theory to reality when Rolls-Royce and easyJet successfully ran a modern jet engine on green hydrogen produced entirely from wind and tidal energy. Unlike battery-electric approaches, hydrogen burns clean — releasing water vapor instead of carbon dioxide — and this test proved a real engine can handle it. Aviation has been one of the hardest sectors to decarbonize, so a confirmed proof of concept opens a genuine path forward. Every major breakthrough in flight history started exactly here: on the ground, with an engine, and a question that finally got answered.

Human eye up close, for article on Gennaris bionic vision system

Monash University develops world’s first bionic eye to fully restore vision in blind people

By / / Good News For Humankind

Gennaris, a bionic vision system from Monash University, could open a path to sight for people whose blindness stems from optic nerve damage — a group that most existing visual aids simply cannot help. The device bypasses the eye entirely, sending signals from a camera headset directly to tiles implanted in the brain, which then create perceivable points of light. Sheep trials confirmed the implants are safe and stable in brain tissue, and human trials are now being planned. If it succeeds, the underlying technology could eventually be adapted to assist people living with paralysis too.

Blood cells under microscope, for article on smart insulin, for article on lab-grown blood cells

First human patients receive transfusions of lab-grown blood cells

By / / Good News For Humankind

Lab-grown blood cells have reached a genuine turning point: manufactured red blood cells grown from stem cells have been safely transfused into human patients for the first time. What makes these cells special is their freshness — unlike donated blood, every lab-grown cell is the same age, meaning they should last closer to the full 120-day lifespan and reduce repeat transfusions. Early participants completed the process with no adverse effects. For millions worldwide living with blood disorders or rare blood types, this science crossing into human trials is the kind of progress that quietly changes everything.

Cancer cells, for article on radioactive implant pancreatic cancer

Radioactive implant wipes tumors in unprecedented pre-clinical success

By / / Good News For Humankind

Pancreatic cancer is one of the hardest diseases medicine has ever faced, and a new implant from Duke University is producing results that researchers say have no match in the existing scientific record. The device injects a radioactive gel directly into tumors, trapping iodine-131 so it radiates from the inside out before safely dissolving into harmless amino acids. Combined with chemotherapy, it eliminated tumors in the majority of mouse models tested. Human trials remain ahead, but for a disease where survival gains have been painfully slow, this early signal is genuinely remarkable.

Measuring Psilocybin Magic Mushroom Micro Doses in Laboratory for A Scientific Experiment, for article on psilocybin therapy

The world’s first Phase 3 psilocybin clinical trial is about to commence

By / / Good News For Humankind

Psilocybin therapy is making history: Compass Pathways will launch the world’s first Phase 3 trial for treatment-resistant depression by the end of 2022, enrolling nearly 1,000 participants across two pivotal studies. This is the threshold every promising drug must cross to become an approved medicine, and no psychedelic compound has crossed it before. For the roughly 100 million people worldwide whose depression doesn’t respond to standard treatments, the stakes are real — current options are few, often invasive, and inconsistently helpful. A single guided dose, if the evidence holds, could reshape what care looks like. Beyond depression, this moment signals that a long-stigmatized class of medicines is finally being tested with the rigor patients deserve.

Newborn baby being held, for article on spina bifida treatment

World-first stem cell therapy trial treats spina bifida before birth

By / / Good News For Humankind

Spina bifida causes nerve damage that accumulates in the womb, and until now, medicine could only respond after that damage was done. A clinical trial at UC Davis Health is changing that window, applying a stem cell patch directly to a fetus’s spine during pregnancy to support repair before birth. The first baby treated was expected to arrive with leg paralysis — instead, she was kicking and wiggling her toes. If results hold across all 35 enrolled patients, this could establish a genuinely new standard of care for a condition that currently offers families very little hope.